0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inhalation Pulmonary Drug Delivery Devices Market Research Report 2026
Published Date: 2026-03-03
|
Report Code: QYRE-Auto-28U19697
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Inhalation Pulmonary Drug Delivery Devices Market Outlook In Depth Analysis Forecast to 2031
BUY CHAPTERS

Global Inhalation Pulmonary Drug Delivery Devices Market Research Report 2026

Code: QYRE-Auto-28U19697
Report
2026-03-03
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Inhalation Pulmonary Drug Delivery Devices Market

The global Inhalation Pulmonary Drug Delivery Devices market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Inhalation Pulmonary Drug Delivery Devices competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Inhalation pulmonary drug delivery devices are specialized medical instruments designed to deliver medication directly to the lungs for the treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other pulmonary disorders. These devices include inhalers, nebulizers, and dry powder inhalers, each employing different mechanisms to aerosolize medication so it can be inhaled efficiently. By delivering drugs directly to the site of action in the lungs, these devices provide rapid relief, improve drug efficacy, and minimize systemic side effects. They are essential tools in respiratory therapy, offering patients convenient and effective means of managing their conditions.
The North American market for Inhalation Pulmonary Drug Delivery Devices is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Inhalation Pulmonary Drug Delivery Devices is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Inhalation Pulmonary Drug Delivery Devices include GlaxoSmithKline (GSK), AstraZeneca, Boehringer Ingelheim, Mylan, Viatris, Novartis, AptarGroup, Chiesi Farmaceutici, Koninklijke Philips, Teva Pharmaceutical Industries, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Inhalation Pulmonary Drug Delivery Devices market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Inhalation Pulmonary Drug Delivery Devices. The Inhalation Pulmonary Drug Delivery Devices market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Inhalation Pulmonary Drug Delivery Devices market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Inhalation Pulmonary Drug Delivery Devices manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Inhalation Pulmonary Drug Delivery Devices Market Report

Report Metric Details
Report Name Inhalation Pulmonary Drug Delivery Devices Market
Segment by Type
  • Metered- dose Inhalers
  • Dry-powder Inhalers
  • Nebulizers
by Application
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis (CF)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline (GSK), AstraZeneca, Boehringer Ingelheim, Mylan, Viatris, Novartis, AptarGroup, Chiesi Farmaceutici, Koninklijke Philips, Teva Pharmaceutical Industries, Monaghan Medical, OMRON, PARI International, Vectura, H&T Presspart
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Inhalation Pulmonary Drug Delivery Devices manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Inhalation Pulmonary Drug Delivery Devices sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Inhalation Pulmonary Drug Delivery Devices Market report?

Ans: The main players in the Inhalation Pulmonary Drug Delivery Devices Market are GlaxoSmithKline (GSK), AstraZeneca, Boehringer Ingelheim, Mylan, Viatris, Novartis, AptarGroup, Chiesi Farmaceutici, Koninklijke Philips, Teva Pharmaceutical Industries, Monaghan Medical, OMRON, PARI International, Vectura, H&T Presspart

What are the Application segmentation covered in the Inhalation Pulmonary Drug Delivery Devices Market report?

Ans: The Applications covered in the Inhalation Pulmonary Drug Delivery Devices Market report are Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis (CF), Idiopathic Pulmonary Fibrosis (IPF), Others

What are the Type segmentation covered in the Inhalation Pulmonary Drug Delivery Devices Market report?

Ans: The Types covered in the Inhalation Pulmonary Drug Delivery Devices Market report are Metered- dose Inhalers, Dry-powder Inhalers, Nebulizers

1 Inhalation Pulmonary Drug Delivery Devices Market Overview
1.1 Product Definition
1.2 Inhalation Pulmonary Drug Delivery Devices by Type
1.2.1 Global Inhalation Pulmonary Drug Delivery Devices Market Value by Type: 2025 vs 2032
1.2.2 Metered- dose Inhalers
1.2.3 Dry-powder Inhalers
1.2.4 Nebulizers
1.3 Inhalation Pulmonary Drug Delivery Devices by Application
1.3.1 Global Inhalation Pulmonary Drug Delivery Devices Market Value by Application: 2025 vs 2032
1.3.2 Asthma
1.3.3 Chronic Obstructive Pulmonary Disease (COPD)
1.3.4 Cystic Fibrosis (CF)
1.3.5 Idiopathic Pulmonary Fibrosis (IPF)
1.3.6 Others
1.4 Global Inhalation Pulmonary Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue 2021–2032
1.4.2 Global Inhalation Pulmonary Drug Delivery Devices Sales 2021–2032
1.4.3 Global Inhalation Pulmonary Drug Delivery Devices Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Inhalation Pulmonary Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Manufacturers (2021–2026)
2.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Inhalation Pulmonary Drug Delivery Devices Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Inhalation Pulmonary Drug Delivery Devices, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Inhalation Pulmonary Drug Delivery Devices, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Inhalation Pulmonary Drug Delivery Devices, Product Types and Applications
2.7 Global Key Manufacturers of Inhalation Pulmonary Drug Delivery Devices, Date of Entry into the Industry
2.8 Global Inhalation Pulmonary Drug Delivery Devices Market Competitive Situation and Trends
2.8.1 Global Inhalation Pulmonary Drug Delivery Devices Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Inhalation Pulmonary Drug Delivery Devices Players Market Share by Revenue
2.8.3 Global Inhalation Pulmonary Drug Delivery Devices Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhalation Pulmonary Drug Delivery Devices Market Scenario by Region
3.1 Global Inhalation Pulmonary Drug Delivery Devices Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2021–2032
3.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2021–2026
3.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Region: 2027–2032
3.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region: 2021–2032
3.3.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region: 2021–2026
3.3.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region: 2027–2032
3.4 North America Inhalation Pulmonary Drug Delivery Devices Market Facts & Figures by Country
3.4.1 North America Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021–2032)
3.4.3 North America Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Inhalation Pulmonary Drug Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021–2032)
3.5.3 Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhalation Pulmonary Drug Delivery Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Inhalation Pulmonary Drug Delivery Devices Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Region (2021–2032)
3.6.3 Asia Pacific Inhalation Pulmonary Drug Delivery Devices Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Inhalation Pulmonary Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021–2032)
3.7.3 Latin America Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021–2032)
3.8.3 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021–2032)
4.1.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021–2026)
4.1.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2027–2032)
4.1.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2021–2032)
4.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021–2032)
4.2.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2021–2026)
4.2.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Type (2027–2032)
4.2.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2021–2032)
4.3 Global Inhalation Pulmonary Drug Delivery Devices Price by Type (2021–2032)
5 Segment by Application
5.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021–2032)
5.1.1 Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021–2026)
5.1.2 Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2027–2032)
5.1.3 Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2021–2032)
5.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021–2032)
5.2.1 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2021–2026)
5.2.2 Global Inhalation Pulmonary Drug Delivery Devices Revenue by Application (2027–2032)
5.2.3 Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2021–2032)
5.3 Global Inhalation Pulmonary Drug Delivery Devices Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GlaxoSmithKline (GSK)
6.1.1 GlaxoSmithKline (GSK) Company Information
6.1.2 GlaxoSmithKline (GSK) Description and Business Overview
6.1.3 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.1.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Company Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Mylan Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Viatris
6.5.1 Viatris Company Information
6.5.2 Viatris Description and Business Overview
6.5.3 Viatris Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.5.5 Viatris Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 AptarGroup
6.7.1 AptarGroup Company Information
6.7.2 AptarGroup Description and Business Overview
6.7.3 AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.7.5 AptarGroup Recent Developments/Updates
6.8 Chiesi Farmaceutici
6.8.1 Chiesi Farmaceutici Company Information
6.8.2 Chiesi Farmaceutici Description and Business Overview
6.8.3 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.8.5 Chiesi Farmaceutici Recent Developments/Updates
6.9 Koninklijke Philips
6.9.1 Koninklijke Philips Company Information
6.9.2 Koninklijke Philips Description and Business Overview
6.9.3 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.9.5 Koninklijke Philips Recent Developments/Updates
6.10 Teva Pharmaceutical Industries
6.10.1 Teva Pharmaceutical Industries Company Information
6.10.2 Teva Pharmaceutical Industries Description and Business Overview
6.10.3 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.11 Monaghan Medical
6.11.1 Monaghan Medical Company Information
6.11.2 Monaghan Medical Description and Business Overview
6.11.3 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.11.5 Monaghan Medical Recent Developments/Updates
6.12 OMRON
6.12.1 OMRON Company Information
6.12.2 OMRON Description and Business Overview
6.12.3 OMRON Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.12.5 OMRON Recent Developments/Updates
6.13 PARI International
6.13.1 PARI International Company Information
6.13.2 PARI International Description and Business Overview
6.13.3 PARI International Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.13.5 PARI International Recent Developments/Updates
6.14 Vectura
6.14.1 Vectura Company Information
6.14.2 Vectura Description and Business Overview
6.14.3 Vectura Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.14.5 Vectura Recent Developments/Updates
6.15 H&T Presspart
6.15.1 H&T Presspart Company Information
6.15.2 H&T Presspart Description and Business Overview
6.15.3 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolio
6.15.5 H&T Presspart Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhalation Pulmonary Drug Delivery Devices Industry Chain Analysis
7.2 Inhalation Pulmonary Drug Delivery Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhalation Pulmonary Drug Delivery Devices Production Mode & Process Analysis
7.4 Inhalation Pulmonary Drug Delivery Devices Sales and Marketing
7.4.1 Inhalation Pulmonary Drug Delivery Devices Sales Channels
7.4.2 Inhalation Pulmonary Drug Delivery Devices Distributors
7.5 Inhalation Pulmonary Drug Delivery Devices Customer Analysis
8 Inhalation Pulmonary Drug Delivery Devices Market Dynamics
8.1 Inhalation Pulmonary Drug Delivery Devices Industry Trends
8.2 Inhalation Pulmonary Drug Delivery Devices Market Drivers
8.3 Inhalation Pulmonary Drug Delivery Devices Market Challenges
8.4 Inhalation Pulmonary Drug Delivery Devices Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Inhalation Pulmonary Drug Delivery Devices Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Inhalation Pulmonary Drug Delivery Devices Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Inhalation Pulmonary Drug Delivery Devices Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Inhalation Pulmonary Drug Delivery Devices Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Inhalation Pulmonary Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Inhalation Pulmonary Drug Delivery Devices Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Inhalation Pulmonary Drug Delivery Devices Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Inhalation Pulmonary Drug Delivery Devices, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Inhalation Pulmonary Drug Delivery Devices, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Inhalation Pulmonary Drug Delivery Devices, Product Types and Applications
 Table 12. Global Key Manufacturers of Inhalation Pulmonary Drug Delivery Devices, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Inhalation Pulmonary Drug Delivery Devices Companies by Tier (Tier 1, Tier 2, Tier 3), based on Inhalation Pulmonary Drug Delivery Devices Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Inhalation Pulmonary Drug Delivery Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (K Units), 2021–2026
 Table 18. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region (2021–2026)
 Table 19. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (K Units), 2027–2032
 Table 20. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region (2027–2032)
 Table 21. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region (2021–2026)
 Table 23. Global Inhalation Pulmonary Drug Delivery Devices Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region (2027–2032)
 Table 25. North America Inhalation Pulmonary Drug Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (K Units), 2021–2026
 Table 27. North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (K Units), 2027–2032
 Table 28. North America Inhalation Pulmonary Drug Delivery Devices Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Inhalation Pulmonary Drug Delivery Devices Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (K Units), 2021–2026
 Table 32. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (K Units), 2027–2032
 Table 33. Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Inhalation Pulmonary Drug Delivery Devices Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Inhalation Pulmonary Drug Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Inhalation Pulmonary Drug Delivery Devices Sales by Country (K Units), 2021–2026
 Table 42. Latin America Inhalation Pulmonary Drug Delivery Devices Sales by Country (K Units), 2027–2032
 Table 43. Latin America Inhalation Pulmonary Drug Delivery Devices Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Inhalation Pulmonary Drug Delivery Devices Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Inhalation Pulmonary Drug Delivery Devices Sales (K Units) by Type (2021–2026)
 Table 51. Global Inhalation Pulmonary Drug Delivery Devices Sales (K Units) by Type (2027–2032)
 Table 52. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2021–2026)
 Table 53. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Type (2027–2032)
 Table 54. Global Inhalation Pulmonary Drug Delivery Devices Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Inhalation Pulmonary Drug Delivery Devices Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2021–2026)
 Table 57. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Type (2027–2032)
 Table 58. Global Inhalation Pulmonary Drug Delivery Devices Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Inhalation Pulmonary Drug Delivery Devices Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Inhalation Pulmonary Drug Delivery Devices Sales (K Units) by Application (2021–2026)
 Table 61. Global Inhalation Pulmonary Drug Delivery Devices Sales (K Units) by Application (2027–2032)
 Table 62. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2021–2026)
 Table 63. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Application (2027–2032)
 Table 64. Global Inhalation Pulmonary Drug Delivery Devices Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Inhalation Pulmonary Drug Delivery Devices Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2021–2026)
 Table 67. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Application (2027–2032)
 Table 68. Global Inhalation Pulmonary Drug Delivery Devices Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Inhalation Pulmonary Drug Delivery Devices Price (US$/Unit) by Application (2027–2032)
 Table 70. GlaxoSmithKline (GSK) Company Information
 Table 71. GlaxoSmithKline (GSK) Description and Business Overview
 Table 72. GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product
 Table 74. GlaxoSmithKline (GSK) Recent Developments/Updates
 Table 75. AstraZeneca Company Information
 Table 76. AstraZeneca Description and Business Overview
 Table 77. AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product
 Table 79. AstraZeneca Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Mylan Company Information
 Table 86. Mylan Description and Business Overview
 Table 87. Mylan Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Mylan Inhalation Pulmonary Drug Delivery Devices Product
 Table 89. Mylan Recent Developments/Updates
 Table 90. Viatris Company Information
 Table 91. Viatris Description and Business Overview
 Table 92. Viatris Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Viatris Inhalation Pulmonary Drug Delivery Devices Product
 Table 94. Viatris Recent Developments/Updates
 Table 95. Novartis Company Information
 Table 96. Novartis Description and Business Overview
 Table 97. Novartis Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Novartis Inhalation Pulmonary Drug Delivery Devices Product
 Table 99. Novartis Recent Developments/Updates
 Table 100. AptarGroup Company Information
 Table 101. AptarGroup Description and Business Overview
 Table 102. AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. AptarGroup Inhalation Pulmonary Drug Delivery Devices Product
 Table 104. AptarGroup Recent Developments/Updates
 Table 105. Chiesi Farmaceutici Company Information
 Table 106. Chiesi Farmaceutici Description and Business Overview
 Table 107. Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product
 Table 109. Chiesi Farmaceutici Recent Developments/Updates
 Table 110. Koninklijke Philips Company Information
 Table 111. Koninklijke Philips Description and Business Overview
 Table 112. Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product
 Table 114. Koninklijke Philips Recent Developments/Updates
 Table 115. Teva Pharmaceutical Industries Company Information
 Table 116. Teva Pharmaceutical Industries Description and Business Overview
 Table 117. Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product
 Table 119. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 120. Monaghan Medical Company Information
 Table 121. Monaghan Medical Description and Business Overview
 Table 122. Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product
 Table 124. Monaghan Medical Recent Developments/Updates
 Table 125. OMRON Company Information
 Table 126. OMRON Description and Business Overview
 Table 127. OMRON Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. OMRON Inhalation Pulmonary Drug Delivery Devices Product
 Table 129. OMRON Recent Developments/Updates
 Table 130. PARI International Company Information
 Table 131. PARI International Description and Business Overview
 Table 132. PARI International Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. PARI International Inhalation Pulmonary Drug Delivery Devices Product
 Table 134. PARI International Recent Developments/Updates
 Table 135. Vectura Company Information
 Table 136. Vectura Description and Business Overview
 Table 137. Vectura Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Vectura Inhalation Pulmonary Drug Delivery Devices Product
 Table 139. Vectura Recent Developments/Updates
 Table 140. H&T Presspart Company Information
 Table 141. H&T Presspart Description and Business Overview
 Table 142. H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product
 Table 144. H&T Presspart Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Inhalation Pulmonary Drug Delivery Devices Distributors List
 Table 148. Inhalation Pulmonary Drug Delivery Devices Customers List
 Table 149. Inhalation Pulmonary Drug Delivery Devices Market Trends
 Table 150. Inhalation Pulmonary Drug Delivery Devices Market Drivers
 Table 151. Inhalation Pulmonary Drug Delivery Devices Market Challenges
 Table 152. Inhalation Pulmonary Drug Delivery Devices Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Inhalation Pulmonary Drug Delivery Devices
 Figure 2. Global Inhalation Pulmonary Drug Delivery Devices Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Inhalation Pulmonary Drug Delivery Devices Market Share by Type: 2025 & 2032
 Figure 4. Metered- dose Inhalers Product Picture
 Figure 5. Dry-powder Inhalers Product Picture
 Figure 6. Nebulizers Product Picture
 Figure 7. Global Inhalation Pulmonary Drug Delivery Devices Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Inhalation Pulmonary Drug Delivery Devices Market Share by Application: 2025 & 2032
 Figure 9. Asthma
 Figure 10. Chronic Obstructive Pulmonary Disease (COPD)
 Figure 11. Cystic Fibrosis (CF)
 Figure 12. Idiopathic Pulmonary Fibrosis (IPF)
 Figure 13. Others
 Figure 14. Global Inhalation Pulmonary Drug Delivery Devices Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Inhalation Pulmonary Drug Delivery Devices Market Size (US$ Million), 2021–2032
 Figure 16. Global Inhalation Pulmonary Drug Delivery Devices Sales (K Units), 2021–2032
 Figure 17. Global Inhalation Pulmonary Drug Delivery Devices Average Price (US$/Unit), 2021–2032
 Figure 18. Inhalation Pulmonary Drug Delivery Devices Report Years Considered
 Figure 19. Inhalation Pulmonary Drug Delivery Devices Sales Share by Manufacturers in 2025
 Figure 20. Global Inhalation Pulmonary Drug Delivery Devices Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Inhalation Pulmonary Drug Delivery Devices Players: Market Share by Revenue in Inhalation Pulmonary Drug Delivery Devices in 2025
 Figure 22. Inhalation Pulmonary Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Inhalation Pulmonary Drug Delivery Devices Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021–2032)
 Figure 25. North America Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Country (2021–2032)
 Figure 26. United States Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021–2032)
 Figure 29. Europe Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Region (2021–2032)
 Figure 37. China Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Southeast Asia Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Colombia Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE Inhalation Pulmonary Drug Delivery Devices Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Inhalation Pulmonary Drug Delivery Devices by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Inhalation Pulmonary Drug Delivery Devices by Type (2021–2032)
 Figure 57. Global Inhalation Pulmonary Drug Delivery Devices Price (US$/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Inhalation Pulmonary Drug Delivery Devices by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Inhalation Pulmonary Drug Delivery Devices by Application (2021–2032)
 Figure 60. Global Inhalation Pulmonary Drug Delivery Devices Price (US$/Unit) by Application (2021–2032)
 Figure 61. Inhalation Pulmonary Drug Delivery Devices Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS